Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

James Patrick Nelli, Jr. net worth and biography

James Nelli, Jr. Biography and Net Worth

President of Health Catalyst

Patrick Nelli joined Health Catalyst in 2013. At Health Catalyst, Patrick helped build the company’s internal business operations group, including the analytics infrastructure and processes. He also helped build Health Catalyst’s CAFÉ Product Line, which aims to be a national repository of healthcare data from Health Catalyst customers’ EDWs and third-party data sources that enables benchmarking and uniquely powerful machine learning algorithms to help health systems efficiently prioritize areas for improvement. Prior to coming to Health Catalyst, Patrick was in the healthcare group at GTCR, a Chicago-based private equity firm, and in the healthcare group at McColl Partners, a boutique investment bank. He has a degree in Physics with a Concentration in Biophysics and Biochemistry from Wake Forest University.

How do I contact James Patrick Nelli, Jr.?: The corporate mailing address for Mr. Nelli, Jr. and other Health Catalyst executives is 3165 MILLROCK DRIVE SUITE 400, SALT LAKE CITY UT, 84121. Health Catalyst can also be reached via phone at (801) 708-6800 and via email at [email protected]. Learn More on James Patrick Nelli, Jr.'s contact information.
Has James Patrick Nelli, Jr. been buying or selling shares of Health Catalyst?: James Patrick Nelli, Jr. has not been actively trading shares of Health Catalyst during the last quarter. Learn More on James Patrick Nelli, Jr.'s trading history.
Who are Health Catalyst's active insiders?: Health Catalyst's insider roster includes Jason Alger (CAO), Daniel Burton (CEO), Bryan Hinton (CTO), Paul Horstmeier (COO), Bryan Hunt (CFO), Linda Llewelyn (Insider), James Nelli, Jr. (President), Daniel Orenstein (CEO), and Anita Pramoda (Director). Learn More on Health Catalyst's active insiders.
Are insiders buying or selling shares of Health Catalyst?: During the last year, Health Catalyst insiders bought shares 1 times. They purchased a total of 49,050 shares worth more than $499,819.50. During the last year, insiders at the sold shares 12 times. They sold a total of 19,034 shares worth more than $194,837.29. The most recent insider tranaction occured on April, 15th when insider Linda Llewelyn sold 2,005 shares worth more than $12,250.55. Insiders at Health Catalyst own 2.7% of the company. Learn More about insider trades at Health Catalyst.
Information on this page was last updated on 4/15/2024.

James Patrick Nelli, Jr. Insider Trading History at Health Catalyst

James Patrick Nelli, Jr. Buying and Selling Activity at Health Catalyst

Health Catalyst Company Overview

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Today's Range

Now: $5.58

$5.51

$5.68

50 Day Range

MA: $7.80

$5.53

$10.26

2 Week Range

Now: $5.58

$5.51

$14.37

Volume

563,701 shs

Average Volume

613,865 shs

Market Capitalization

$326.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29